Topics

Phage Therapy Firm APT Lands DoD Contract for Antibiotic Alternative

08:00 EST 15 Jan 2020 | Xconomy

The Department of Defense has awarded Adaptive Phage Therapeutics a $10.2 million contract to help advance its experimental therapy for the treatment of multidrug-resistant infections. Gaithersburg, MD-based Adaptive Phage Therapeutics (APT) says it will pursue a two-year multi-site clinical trial as it looks to get the OK from the FDA, which considers phage to be […]

Original Article: Phage Therapy Firm APT Lands DoD Contract for Antibiotic Alternative

NEXT ARTICLE

More From BioPortfolio on "Phage Therapy Firm APT Lands DoD Contract for Antibiotic Alternative"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...